Abstract: Due to non⁃invasive and repeatable characteristics, ultrasound, which may clearly display hepatic fibrosis and related pathologies caused by Schistosoma infections, is a vital tool for schistosomiasis screening and evaluation of therapeutic efficacy in endemic areas. With the progress towards elimination of schistosomiasis, there is an increasing reduction in new infections in China, and intensified management of previous infections and a delayed progress of hepatic fibrosis are therefore critical to the target of schistosomiasis elimination in the country. On May 2025, National Institute of Parasitic Diseases, Chinese Centre for Disease Control and Prevention convened an international seminar on ultrasound diagnosis of schistosomiasis japonica⁃induced hepatic fibrosis, which included over 30 experts from China, Switzerland and the United States, and achieved on expert consensus on the ultrasound diagnostic pathway for schistosomiasis japonica⁃induced hepatic fibrosis, based on a review of the historical development of standardization of ultrasound diagnosis, aiming to provide insights into the application of ultrasound technology in guiding the formulation of screening of schistosomiasis⁃induced hepatic fibrosis and interventions.  

Key words: Schistosomiasis japonica, Hepatic fibrosis, Ultrasound, Diagnostic pathway, Expert consensus

摘要： 超声检查因其无创、可重复等特点，能清晰显示血吸虫感染引起的肝纤维化及相关病变，是流行区血吸虫病筛查和疗效评估的重要手段。 随着我国血吸虫病防治工作的深入开展，新发感染已日趋减少，加强对既往感染者的管理、延缓肝纤维化进展，对实现消除目标至关重要。为此，中国疾病预防控制中心寄生虫病预防控制所于2025年5月组织来自国内多家血吸虫病防治、科研机构以及瑞士、美国的30余位专家，在回顾超声诊断标准化发展历程的基础上，研讨形成了日本血吸虫病肝纤维化超声诊断路径专家共识，旨在为超声技术应用于血吸虫病肝纤维化筛查及干预方案制定提供科学依据。

关键词: 日本血吸虫病, 肝纤维化, 超声, 诊断路径, 专家共识